Summit Global Investments’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,785
Closed -$339K 554
2024
Q2
$339K Buy
14,785
+2,683
+22% +$82.7K 0.02% 405
2024
Q1
$479K Buy
12,102
+3,892
+47% +$154K 0.04% 334
2023
Q4
$325K Sell
8,210
-242
-3% -$10.1K 0.02% 415
2023
Q3
$375K Buy
8,452
+310
+4% +$13.5K 0.03% 388
2023
Q2
$354K Buy
8,142
+1,642
+25% +$72.2K 0.02% 397
2023
Q1
$283K Sell
6,500
-1,000
-13% -$44.2K 0.02% 435
2022
Q4
$280K Buy
+7,500
New +$290K 0.02% 402

Other funds holding NRC

Summit Global Investments's NRC Position: Q3 2024 in Review

Summit Global Investments sold out of NRC Health Common Stock (NRC) in Q3 2024, closing a stake of 14,785 shares — an estimated $339K sold.

Summit Global Investments first reported a position in NRC in Q4 2022 and held it in 7 quarters. The position peaked at $479K in Q1 2024. 138 funds tracked by Wall St. Rank hold NRC as of Q3 2024.

  • Summit Global Investments reported no remaining NRC Health Common Stock position as of Q3 2024 after selling out during the quarter.
  • Summit Global Investments sold 14,785 NRC Health Common Stock shares in Q3 2024, an estimated $339K.
  • Summit Global Investments first reported a position in NRC Health Common Stock in Q4 2022 and held it in 7 quarters.
  • Summit Global Investments's NRC Health Common Stock position peaked at $479K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2024.

Based on Summit Global Investments's 13F filing for Q3 2024, filed 31 Oct 2024.